These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 34660811)

  • 1. The Effectiveness of Traditional Chinese Medicine Jinlida Granules on Glycemic Variability in Newly Diagnosed Type 2 Diabetes: A Double-Blinded, Randomized Trial.
    Pan J; Xu Y; Chen S; Tu Y; Mo Y; Gao F; Zhou J; Hu C; Jia W
    J Diabetes Res; 2021; 2021():6303063. PubMed ID: 34660811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Efficacy and Safety of Chinese Herbal Medicine Jinlida as Add-On Medication in Type 2 Diabetes Patients Ineffectively Managed by Metformin Monotherapy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial.
    Lian F; Tian J; Chen X; Li Z; Piao C; Guo J; Ma L; Zhao L; Xia C; Wang CZ; Yuan CS; Tong X
    PLoS One; 2015; 10(6):e0130550. PubMed ID: 26098833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Chinese herbal medicine Jinlida in type 2 diabetes patients based on stratification: Results of subgroup analysis from a 12-week trial.
    Tian J; Lian F; Yang L; Tong X
    J Diabetes; 2018 Feb; 10(2):112-120. PubMed ID: 28418191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jinlida granules combined with metformin improved the standard-reaching rate of blood glucose and clinical symptoms of patients with type 2 diabetes: secondary analysis of a randomized controlled trial.
    Kang X; Sun Y; Duan Y; Zhang Y; An X; Jin D; Lian F; Tong X
    Front Endocrinol (Lausanne); 2023; 14():1142327. PubMed ID: 37305056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial.
    Jia W; Zhang P; Zhu D; Duolikun N; Li H; Bao Y; Li X;
    PLoS Med; 2021 Sep; 18(9):e1003754. PubMed ID: 34547030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of traditional Chinese medicine Jinlida granules as an add-on therapy for type 2 diabetes: A system review and meta-analysis of randomized controlled trials.
    Lian F; Jin D; Bao Q; Zhao Y; Tong X
    J Diabetes; 2019 Jul; 11(7):540-551. PubMed ID: 30430757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs.
    Luo M; Kong X; Wang H; Zhai X; Cai T; Ding B; Hu Y; Jing T; Su X; Li H; Ma J
    J Diabetes Res; 2020; 2020():6666403. PubMed ID: 33299890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities: The FOCUS Randomized Clinical Trial.
    Ji H; Zhao X; Chen X; Fang H; Gao H; Wei G; Zhang M; Kuang H; Yang B; Cai X; Su Y; Piao C; Zhao S; Li L; Sun W; Xu T; Xu Q; Fan Y; Ye J; Yao C; Shang M; Song G; Chen L; Zheng Q; Xiao X; Yan L; Lian F; Tong X; Jia Z;
    JAMA Intern Med; 2024 Jul; 184(7):727-735. PubMed ID: 38829648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of type 2 diabetes mellitus using the traditional Chinese medicine Jinlida as an add-on medication: A systematic review and meta-analysis of randomized controlled trials.
    Zhao X; Liu L; Liu J
    Front Endocrinol (Lausanne); 2022; 13():1018450. PubMed ID: 36325446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial.
    Henry RR; Strange P; Zhou R; Pettus J; Shi L; Zhuplatov SB; Mansfield T; Klein D; Katz A
    Diabetes Technol Ther; 2018 Nov; 20(11):715-724. PubMed ID: 30222367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basis and Design of a Randomized Clinical Trial to Evaluate the Effect of Jinlida Granules on Metabolic Syndrome in Patients With Abnormal Glucose Metabolism.
    Jin D; Hou L; Han S; Chang L; Gao H; Zhao Y; Zhao S; An X; Song G; Piao C; Lian F; Xiao-Lin T; Jia Z
    Front Endocrinol (Lausanne); 2020; 11():415. PubMed ID: 32670199
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative study of the effects of a dipeptidyl peptidase-IV inhibitor and sulfonylurea on glucose variability in patients with type 2 diabetes with inadequate glycemic control on metformin.
    Kim HS; Shin JA; Lee SH; Kim ES; Cho JH; Son HY; Yoon KH
    Diabetes Technol Ther; 2013 Oct; 15(10):810-6. PubMed ID: 24050737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of liraglutide vs. NPH in combination with metformin on blood glucose fluctuations assessed using continuous glucose monitoring in patients with newly diagnosed type 2 diabetes.
    Ma Z; Chen R; Liu Y; Yu P; Chen L
    Int J Clin Pharmacol Ther; 2015 Nov; 53(11):933-9. PubMed ID: 26365337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acupuncture paired with herbal medicine for prediabetes: study protocol for a randomized controlled trial.
    Li X; Liu H; Feng H; Xian Z; Chen Y; Chen J; Tang C; Lai X; Lan X; Huang H; Yu D
    Trials; 2017 Jun; 18(1):297. PubMed ID: 28659162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 5:2 Intermittent Fasting Meal Replacement Diet and Glycemic Control for Adults With Diabetes: The EARLY Randomized Clinical Trial.
    Guo L; Xi Y; Jin W; Yuan H; Qin G; Chen S; Zhang L; Liu Y; Cheng X; Liu W; Yu D
    JAMA Netw Open; 2024 Jun; 7(6):e2416786. PubMed ID: 38904963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Danzhijiangtang capsule on monocyte chemoattractant protein-1 mRNA expression in newly diagnosed diabetes subclinical vascular lesions.
    Fang ZH; Liu Y; Bao TT; Ni YQ; Liu J; Shi GB; Wu JP; Yang JP; Zhang H
    World J Gastroenterol; 2013 May; 19(19):2963-8. PubMed ID: 23704830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of generic exenatide injection in Chinese patients with type 2 diabetes: a multicenter, randomized, controlled, non-inferiority trial.
    Yang J; Xiao W; Guo L; Li Q; Zhong L; Yang J; Yang J; Gao Y; Tian Q; Hong T
    Acta Diabetol; 2020 Aug; 57(8):991-1000. PubMed ID: 32206903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Chinese Herbal Medicine Jinlida Granule in Treatment of Patients with Impaired Glucose Tolerance.
    Shi YL; Liu WJ; Zhang XF; Su WJ; Chen NN; Lu SH; Wang LY; Shi XL; Li ZB; Yang SY
    Chin Med J (Engl); 2016 Oct; 129(19):2281-6. PubMed ID: 27647185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.